The table below shows RAPT Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
Revenue
-
$0.00
$1.53M
$3.81M
$5.04M
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$107.22M
$101.00M
$67.08M
$56.98M
$45.48M
$34.91M
SG&A
$28.88M
RAPT annual revenue (10-K history)
RAPT Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2023. That is down 100.0% from $1.53M in fiscal 2022. Figures come from the company's audited annual reports as filed with the SEC.